Gene Therapy For Children With Variant Late Infantile Neuronal Ceroid Lipofuscinosis 6 (vLINCL6) Disease
Condition(s):Variant Late-Infantile Neuronal Ceroid LipofuscinosisLast Updated:March 8, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Variant Late-Infantile Neuronal Ceroid LipofuscinosisLast Updated:March 8, 2023Completed
Condition(s):Batten Disease; Late Infantile Neuronal Ceroid LipofuscinosisLast Updated:July 24, 2020Completed
Condition(s):Batten Disease; Late Infantile Neuronal Ceroid LipofuscinosisLast Updated:July 29, 2020Completed
Condition(s):Batten Disease; Late-Infantile Neuronal Ceroid LipofuscinosisLast Updated:February 2, 2021Completed
Condition(s):Late-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)Last Updated:November 1, 2021Withdrawn
Condition(s):Jansky-Bielschowsky Disease; Batten Disease; Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2; CLN2 DiseaseLast Updated:March 8, 2019Completed
Condition(s):Late Infantile Neuronal Ceroid Lipofuscinosis; Batten DiseaseLast Updated:August 31, 2020Completed
Condition(s):Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2Last Updated:January 31, 2024Active, not recruiting
Condition(s):Late Infantile Neuronal Ceroid Lipofuscinosis; Batten DiseaseLast Updated:May 4, 2016Terminated
Condition(s):Infantile Neronal Ceroid LipofuscinosisLast Updated:October 27, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.